Table 2.
Demographic and clinical characteristic.
|
n(%) or median[IQR] |
p- value | |||
|---|---|---|---|---|
| Total |
With fatigue |
Without fatigue |
||
| (n = 223) | (n = 35) | (n = 188) | ||
| Characteristics | ||||
| Age, y | 71 (62, 81) | 67 (61, 82) | 71 (62, 80) | 0.124 |
| Gender | ||||
| Female | 120 (53.8) | 22 (62.9) | 98 (52.1) | 0.720 |
| Male | 103 (46.2) | 13 (37.1) | 90 (47.9) | |
| BMI | 23.1(21.0,25.4) | 23.9(21.4,26.3) | 23.1(20.9,25.3) | 0.382 |
| Comorbidities | ||||
| Any | 180 (80.7) | 31 (88.6) | 149 (79.3) | 0.249 |
| Hypertension | 121 (54.3) | 19 (54.3) | 102 (54.3) | 0.680 |
| Diabetes | 48 (21.5) | 6 (17.1) | 42 (22.3) | 0.376 |
| Cardiac disease | 69 (30.9) | 14 (40.0) | 55 (29.3) | 0.256 |
| Neurology disease | 64 (28.7) | 14 (40.0) | 50 (26.6) | 0.093 |
| Cerebrovascular disease | 44 (19.7) | 9 (25.7) | 35 (18.6) | 0.295 |
| Dementia | 13 (5.8) | 2 (5.7) | 11 (5.9) | 0.926 |
| Parkinson disease | 11 (4.9) | 4 (11.4) | 7 (3.7) | 0.066 |
| Emotional disorder | 7 (3.1) | 2 (5.7) | 5 (2.7) | 0.353 |
| Epilepsy | 3 (1.3) | 1 (2.9) | 2 (1.1) | 0.417 |
| Chronic lung disease | 33 (14.8) | 5 (14.3) | 28 (14.9) | 0.699 |
| Chronic liver disease | 10 (4.5) | 4 (11.4) | 6 (3.2) | 0.043∗ |
| Chronic kidney disease | 6 (2.7) | 2 (5.7) | 4 (2.1) | 0.248 |
| Cancer | 11 (4.9) | 3 (8.6) | 8 (4.3) | 0.289 |
| Comorbidities≥2 | 130 (58.3) | 22 (62.9) | 108 (57.4) | 0.483 |
| Vaccinated | 95 (42.6) | 11 (31.4) | 84 (44.7) | 0.271 |
| Booster injection | 53 (23.8) | 4 (11.4) | 49 (26.1) | 0.587 |
| Degree of severity | ||||
| Mild | 178 (79.8) | 29 (82.9) | 149 (79.3) | 0.796 |
| Moderate | 45 (20.2) | 6 (17.1) | 39 (20.7) | |
| Treatment | ||||
| Traditional Chinese Medicine | 211 (94.6) | 34 (97.1) | 177 (94.1) | 0.479 |
| Antibiotics | 50 (22.4) | 12 (34.3) | 38 (20.2) | 0.058 |
| Anticoagulation | 31 (13.9) | 6 (17.1) | 25 (13.3) | 0.496 |
| Glucocorticoid | 17 (7.6) | 6 (17.1) | 11 (5.9) | 0.019∗ |
| Thymosin | 43 (19.3) | 8 (22.9) | 35 (18.6) | 0.560 |
| Paxlovid | 139 (62.3) | 17 (48.6) | 122 (64.9) | 0.037∗ |
| Nutritional support | 62 (27.8) | 14 (40.0) | 48 (25.5) | 0.224 |
| Clinical outcomes | ||||
| Length of hospitalization, d | 9 (5, 11) | 10 (9, 13) | 8.5 (5, 11) | 0.002∗∗ |